在质母细胞瘤中准CDK4/6
Xia Zhang1,2, Like Ning1, Hongshuai Wu3
1Department of Cell Biology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, Jiangsu, China. linfee@me.com.
Nanoscale
|June 6, 2023
概括
这项研究开发了一种基于纤维素的水凝,用于将palbociclib (PB) 输送到大脑,通过持续释放和ROS生成增强其抗质母细胞瘤 (GBM) 作用. 新型水凝在临床前模型中改善了治疗结果.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术 纳米技术
- 在瘤学瘤学.
背景情况:
- 质母细胞瘤 (GBM) 仍然是一个具有挑战性的脑瘤,尽管有积极的治疗方法,预后不佳.
- 血脑屏障的有限透限制了像palbociclib (PB) 这样的药物的疗效.
研究的目的:
- 研究一种基于纤维素的水凝,用于在脑部部部位输送palbociclib (PB),以治疗质母细胞瘤 (GBM).
- 评估水凝通过受控释放和活性氧物种 (ROS) 生产来增强PB的抗GBM作用的能力.
主要方法:
- 帕尔博西克利布 (PB) 被封装在一个纤维素纳米晶水凝中,与聚多巴胺,Cu2+和六胺 (PB@PH/Cu-CNCs) 交联.
- 水凝显示了持续的药物释放和对酸反应的脱聚合.
- Cu2+催化了一种类似芬顿的反应,产生PB增强的ROS,诱导GBM细胞衰老和亡.
主要成果:
- PB@PH/Cu-CNCs在体内显示持续的药物保留和受控释放.
- 释放的Cu2+和PB的组合有效诱导了GBM细胞死亡.
- 水凝配方在体外和在正位质瘤模型中,与免费PB或无药水凝相比,表现出更高的抗GBM疗效.
结论:
- 在位注射带PB的水凝是一种有效的策略,用于脑部输送palbociclib.
- 这种方法通过利用Cu2+介导的芬顿类反应来增加ROS产生的反GBM疗效.
更多相关视频
12:55Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
Published on: February 16, 2015
21.5K
10:28Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells
Published on: January 10, 2018
8.4K
相关概念视频
02:34Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
02:15M-Cdk Drives Transition Into Mitosis
5.6K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.6K
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K